Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
- PMID: 11017144
- DOI: 10.1038/80466
Loss of p14ARF in tumor cells facilitates replication of the adenovirus mutant dl1520 (ONYX-015)
Abstract
The adenovirus mutant dl1520 (ONYX-015) does not express the E1B-55K protein that binds and inactivates p53. This virus replicates in tumor cells with mutant p53, but not in normal cells with functional p53. Although intra-tumoral injection of dl1520 shows promising responses in patients with solid tumors, previous in vitro studies have not established a close correlation between p53 status and dl1520 replication. Here we identify loss of p14ARF as a mechanism that allows dl1520 replication in tumor cells retaining wild-type p53. We demonstrate that the re-introduction of p14ARF into tumor cells with wild-type p53 suppresses replication of dl1520 in a p53-dependent manner. Our study supports the therapeutic use of dl1520 in tumors with lesions within the p53 pathway other than mutation of p53.
Similar articles
-
Late viral RNA export, rather than p53 inactivation, determines ONYX-015 tumor selectivity.Cancer Cell. 2004 Dec;6(6):611-23. doi: 10.1016/j.ccr.2004.11.012. Cancer Cell. 2004. PMID: 15607965
-
Interactions between adenovirus proteins and the p53 pathway: the development of ONYX-015.Semin Cancer Biol. 2000 Dec;10(6):453-9. doi: 10.1006/scbi.2000.0336. Semin Cancer Biol. 2000. PMID: 11170867 Review.
-
ONYX-015 selectivity and the p14ARF pathway.Oncogene. 2000 Dec 27;19(56):6670-2. doi: 10.1038/sj.onc.1204096. Oncogene. 2000. PMID: 11426653
-
An N-terminal p14ARF peptide blocks Mdm2-dependent ubiquitination in vitro and can activate p53 in vivo.Oncogene. 2000 May 4;19(19):2312-23. doi: 10.1038/sj.onc.1203593. Oncogene. 2000. PMID: 10822382
-
Does the antitumor adenovirus ONYX-015/dl1520 selectively target cells defective in the p53 pathway?J Virol. 2001 Jun;75(12):5443-7. doi: 10.1128/JVI.75.12.5443-5447.2001. J Virol. 2001. PMID: 11356950 Free PMC article. Review. No abstract available.
Cited by
-
Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.J Virol. 2001 Mar;75(6):2857-65. doi: 10.1128/JVI.75.6.2857-2865.2001. J Virol. 2001. PMID: 11222711 Free PMC article.
-
Ral GTPase down-regulation stabilizes and reactivates p53 to inhibit malignant transformation.J Biol Chem. 2014 Nov 7;289(45):31296-309. doi: 10.1074/jbc.M114.565796. Epub 2014 Sep 10. J Biol Chem. 2014. PMID: 25210032 Free PMC article.
-
RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses.Cancer Gene Ther. 2009 Nov;16(11):810-9. doi: 10.1038/cgt.2009.29. Epub 2009 May 1. Cancer Gene Ther. 2009. PMID: 19407849 Free PMC article.
-
Antiviral action of the tumor suppressor ARF.EMBO J. 2006 Sep 20;25(18):4284-92. doi: 10.1038/sj.emboj.7601302. Epub 2006 Sep 7. EMBO J. 2006. PMID: 16957780 Free PMC article.
-
A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation.Sci Rep. 2015 Dec 15;5:18231. doi: 10.1038/srep18231. Sci Rep. 2015. PMID: 26667181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous